YIXINTANG PHARMACEUTICAL GROUP CO., LTD.

Yixintang Pharmaceutical Group Co., Ltd.

002727

CNE100001WJ8

Drug Retailers

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-14 pm EDT			5-day change	1st Jan Change
20.72 ^CNY	+2.93%		+7.36%	-10.54%

Mar. 19	Yixintang Pharmaceutical's Profit Falls 46% as Revenue Stays Nearly Flat	MT
Mar. 18	Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Yunnan Hongxiang Yixintang Pharmaceutical Co., Ltd. Elects Guo Chunli as Non-Independent Director

November 17, 2016 at 03:31 am EST

Yunnan Hongxiang Yixintang Pharmaceutical Co., Ltd. has elected Guo Chunli as non-independent director at the EGM held on November 16, 2016.

Latest news about Yixintang Pharmaceutical Group Co., Ltd.

Yixintang Pharmaceutical's Profit Falls 46% as Revenue Stays Nearly Flat	Mar. 19	MT
Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 18	CI
Yixintang Pharmaceutical Group Co., Ltd. completed the acquisition of Assets and Inventories of 10 Stores from Yiliang Yijun Pharmaceutical Co., Ltd.	Feb. 21	CI
Yunzhong Pharmaceutical Co., Ltd. announced that it expects to receive CNY 20 million in funding from Yixintang Pharmaceutical Group Co., Ltd. and another investor	Feb. 21	CI
Yixintang Pharmaceutical Group Co., Ltd. agreed to acquire Assets and Inventories of 10 Stores from Yiliang Yijun Pharmaceutical Co., Ltd. for CNY 8.40 million.	Dec. 27	CI
Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
Yixintang Pharmaceutical to Buy 43 Stores From Local Peer For 87 Million Yuan	23-09-04	MT
Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-18	CI
Yixin Convenience Store Chain Co., Ltd. announced that it expects to receive CNY 38 million in funding from Yixintang Pharmaceutical Group Co., Ltd.	23-06-19	CI
Yixintang Pharmaceutical Group Co., Ltd. announced a financing transaction	23-05-31	CI
Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-20	CI
Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-17	CI
Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
UBS Adjusts Yixintang Pharmaceutical Group's Price Target to 35 Yuan From 51 Yuan, Keeps at Buy	22-09-02	MT
Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-17	CI
Beijing Mulls Banning Internet Healthcare Firms From Selling Drugs Online	22-06-22	MT
Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-29	CI
UBS Adjusts Yixintang Pharmaceutical’s Price Target to 51 Yuan From 56.50 Yuan, Keeps at Buy	22-04-01	MT
Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-14	CI
Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-29	CI
Yixintang Pharmaceutical Co., Ltd. announced that it has received CNY 250 million in funding from Yixintang Pharmaceutical Group Co., Ltd.	21-07-26	CI
Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-07-23	CI
Yixintang Pharmaceutical Co., Ltd. announced that it expects to receive CNY 250 million in funding from Yixintang Pharmaceutical Group Co., Ltd.	21-07-08	CI
Yixintang Pharmaceutical : Pharma to List Over 2 Million Newly Unlocked Restricted Shares	21-06-02	MT
Yixintang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-28	CI

Chart Yixintang Pharmaceutical Group Co., Ltd.

Duration

Period

Chart Yixintang Pharmaceutical Group Co., Ltd.

More charts

Yixintang Pharmaceutical Group Co., Ltd., formerly Yunnan Hongxiang Yixintang Pharmaceutical Co., Ltd., is a China-based company principally engaged in the pharmaceutical chain retailing and pharmaceutical wholesaling businesses. The Companyâs main products include traditional Chinese medicines, western medicines, medical equipment, birth control products and disinfection products, among others. The Company distributes its products through regular chain drugstores. The Company mainly operates its business in domestic market, with southwest area of China as its main market.

Sector

Drug Retailers

Calendar

2024-04-26 - Q4 2023 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Yixintang Pharmaceutical Group Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

20.72 CNY

Average target price

27.74 CNY

Spread / Average Target

+33.88%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Drug Retailers

	1st Jan change	Capi.
YIXINTANG PHARMACEUTICAL GROUP CO., LTD.	-10.54%	1.71B
WALGREENS BOOTS ALLIANCE, INC.	-32.40%	15.23B
JD HEALTH INTERNATIONAL INC.	-40.15%	9.9B
MATSUKIYOCOCOKARA & CO.	-4.25%	6.83B
YIFENG PHARMACY CHAIN CO., LTD.	+9.14%	6.1B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-37.97%	5.59B
NAHDI MEDICAL COMPANY	+5.40%	5B
CORPORATIVO FRAGUA, S.A.B. DE C.V.	+49.08%	4.21B
CLICKS GROUP LIMITED	-11.42%	3.65B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	-11.73%	3.46B

Other Drug Retailers

Yixintang Pharmaceutical Group Co., Ltd.

Equities

002727

CNE100001WJ8

Drug Retailers

Yunnan Hongxiang Yixintang Pharmaceutical Co., Ltd. Elects Guo Chunli as Non-Independent Director

Latest news about Yixintang Pharmaceutical Group Co., Ltd.

Chart Yixintang Pharmaceutical Group Co., Ltd.

Company Profile

Income Statement Evolution

Ratings for Yixintang Pharmaceutical Group Co., Ltd.

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Drug Retailers